JP2007519654A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007519654A5 JP2007519654A5 JP2006550004A JP2006550004A JP2007519654A5 JP 2007519654 A5 JP2007519654 A5 JP 2007519654A5 JP 2006550004 A JP2006550004 A JP 2006550004A JP 2006550004 A JP2006550004 A JP 2006550004A JP 2007519654 A5 JP2007519654 A5 JP 2007519654A5
- Authority
- JP
- Japan
- Prior art keywords
- ring
- het
- phenyl
- defined above
- het ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C**S(N(C)C(C(*)C(*C(C)(C)C)C(*)(*)*C)C(*)=O)(=O)=O Chemical compound C**S(N(C)C(C(*)C(*C(C)(C)C)C(*)(*)*C)C(*)=O)(=O)=O 0.000 description 2
- FSCXETXPBDILFC-UHFFFAOYSA-N CCCC(C)OC(C)(C(C)C(C)CN(C)C)OC Chemical compound CCCC(C)OC(C)(C(C)C(C)CN(C)C)OC FSCXETXPBDILFC-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004004974A DE102004004974A1 (de) | 2004-01-31 | 2004-01-31 | Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen |
| DE102004004974.2 | 2004-01-31 | ||
| PCT/EP2005/000417 WO2005073236A2 (de) | 2004-01-31 | 2005-01-18 | Thieno-iminosäure-derivate als inhibitoren von matrix-metalloproteinasen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007519654A JP2007519654A (ja) | 2007-07-19 |
| JP2007519654A5 true JP2007519654A5 (https=) | 2008-02-28 |
| JP4733648B2 JP4733648B2 (ja) | 2011-07-27 |
Family
ID=34801393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006550004A Expired - Fee Related JP4733648B2 (ja) | 2004-01-31 | 2005-01-18 | マトリックスメタロプロテイナーゼ阻害剤としての使用のためのチエノ−イミノ酸誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7399770B2 (https=) |
| EP (1) | EP1723148A2 (https=) |
| JP (1) | JP4733648B2 (https=) |
| DE (1) | DE102004004974A1 (https=) |
| WO (1) | WO2005073236A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10361075A1 (de) * | 2003-12-22 | 2005-07-28 | Pac Tech - Packaging Technologies Gmbh | Verfahren und Vorichtung zur Trocknung von Schaltungssubstraten |
| DE102004053982B4 (de) * | 2004-11-09 | 2011-07-21 | Koop, Daniel, 25337 | Verwendung von Reibhölzern und Verfahren zum Räuchern von Nahrungsmittelprodukten |
| DE102005015040A1 (de) * | 2005-03-31 | 2006-10-05 | Sanofi-Aventis Deutschland Gmbh | Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
| SG10201510665WA (en) | 2009-12-04 | 2016-01-28 | Sunovion Pharmaceuticals Inc | Multicycle Compounds And Pharmaceutical Compositions Useful For The Treatment Of Neurological Disorders |
| MA45795A (fr) | 2016-07-29 | 2019-06-05 | Sunovion Pharmaceuticals Inc | Composés et compositions, et utilisations associées |
| PT3494119T (pt) | 2016-07-29 | 2024-12-10 | Pgi Drug Discovery Llc | Compostos e composições e seus usos |
| MX390141B (es) | 2017-02-16 | 2025-03-20 | Sunovion Pharmaceuticals Inc | Metodos para tratar esquizofrenia |
| CA3070993C (en) | 2017-08-02 | 2025-05-20 | Sunovion Pharmaceuticals Inc. | ISOCHROMANE COMPOUNDS AND THEIR USES |
| UA130249C2 (uk) | 2018-02-16 | 2025-12-31 | Сумітомо Фарма Америка, Інк. | Солі, кристалічні форми і способи їх отримання |
| EP3938045A1 (en) | 2019-03-14 | 2022-01-19 | Sunovion Pharmaceuticals Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
| CA3180115A1 (en) | 2020-04-14 | 2021-10-21 | Sunovion Pharmaceuticals Inc. | (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5294621A (en) | 1992-10-07 | 1994-03-15 | Ortho Pharmaceutical Corporation | Thieno tetrahydropyridines useful as class III antiarrhythmic agents |
| US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| AU7205894A (en) | 1993-06-08 | 1995-01-03 | Neogenix, Inc. | Purified natural and synthetic compounds for the treatment of osteoarthritis |
| US5863949A (en) | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| ES2153031T4 (es) * | 1995-04-20 | 2001-05-16 | Pfizer | Derivados del acido arilsulfonil hidroxamico como inhibidores de mmp y tnf. |
| US6207672B1 (en) | 1995-11-13 | 2001-03-27 | Aventis Pharma Deutschland Gmbh | Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acids |
| FR2748026B1 (fr) * | 1996-04-26 | 1998-06-05 | Adir | Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| RU2203274C2 (ru) | 1996-08-28 | 2003-04-27 | Дзе Проктер Энд Гэмбл Компани | Спироциклические ингибиторы металлопротеаз |
| EP1003751A1 (en) * | 1997-08-04 | 2000-05-31 | Amgen Inc. | Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| FR2825705B1 (fr) | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
| WO2003016248A2 (en) * | 2001-08-17 | 2003-02-27 | Bristol-Myers Squibb Company Patent Department | Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) |
| WO2003089416A1 (de) * | 2002-04-22 | 2003-10-30 | Ibfb Gmbh | Substituierte pyrimidin-2,4(1h,3h)-dione als matrix metalloproteinase (mmp) inhibitoren |
| CN1187332C (zh) * | 2002-04-26 | 2005-02-02 | 中国科学院上海有机化学研究所 | 四氢异喹啉羟肟酸磺酰胺类化合物、合成方法及其用途 |
-
2004
- 2004-01-31 DE DE102004004974A patent/DE102004004974A1/de not_active Withdrawn
-
2005
- 2005-01-18 EP EP05700992A patent/EP1723148A2/de not_active Withdrawn
- 2005-01-18 WO PCT/EP2005/000417 patent/WO2005073236A2/de not_active Ceased
- 2005-01-18 JP JP2006550004A patent/JP4733648B2/ja not_active Expired - Fee Related
-
2006
- 2006-07-31 US US11/461,189 patent/US7399770B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004516314A5 (https=) | ||
| JP2006524222A5 (https=) | ||
| JP2007519654A5 (https=) | ||
| JP2011527667A5 (https=) | ||
| JP2011037841A5 (https=) | ||
| JP2016501185A5 (https=) | ||
| CA2545427A1 (en) | Selective kinase inhibitors | |
| JP2013512915A5 (https=) | ||
| JP2009502743A5 (https=) | ||
| AR056327A1 (es) | Compuestos de nucleosidos para el tratamiento de infecciones virales | |
| JP2009542721A5 (https=) | ||
| JP2013542996A5 (https=) | ||
| JP2008505157A5 (https=) | ||
| JP2013540755A5 (https=) | ||
| JP2010536887A5 (https=) | ||
| JP2007516180A5 (https=) | ||
| JP2014506907A5 (https=) | ||
| JP2010532387A5 (https=) | ||
| JP2013507423A5 (https=) | ||
| JP2013514980A5 (https=) | ||
| JP2009535307A5 (https=) | ||
| JP2010504286A5 (https=) | ||
| JP2008505117A5 (https=) | ||
| JP2010504344A5 (https=) | ||
| JP2013510178A5 (https=) |